Virtual Medicinal Product (VMP) - Larotrectinib 25mg capsules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Larotrectinib 25mg capsules | Start Date 12-02-2021 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01EX12
| Code | Start Date | End Date |
|---|---|---|
| 39389911000001103 | 12-02-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Larotrectinib sulfate | Based on Base Substance | Larotrectinib | 25 mg |
Name
Larotrectinib sulfate
Basis of strength description
Based on Base Substance
BOSS
Larotrectinib
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
Parent Products
-
VTMLarotrectinib
-
VMP(Current) Larotrectinib 25mg capsules
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 56 capsule |